Print Page

Medicine recalls

Australia: Metagenics NasoClear: Recall - potential bacterial contamination
Therapeutic Goods Administration (TGA) advised consumers and health professionals that Health World Limited, in consultation with the TGA, is recalling batch number 80789 of Metagenics NasoClear 30 mL nasal spray (expiry May 2018).

Metagenics NasoClear is a complementary medicine product that combines a saline solution scented with essential oils. It has been identified that some products from the affected batch may contain Staphylococcus aureus, commonly known as golden staph. Golden staph is commonly carried on the skin or in the nose of healthy people. However, particularly in children the elderly or immuno-compromised people, it can cause infections, ranging from mild to, in the most severe cases, life-threatening infections, such as pneumonia, meningitis or blood-stream infections. Batch number 80789 has only been supplied since 24 June 2016 and no other batches of Metagenics products are affected. As of 20 September, no adverse events relating to this issue have been reported in Australia.

Consumers are advised to check the batch number of Metagenics NasoClear of they have the product, and return the affected batch to the place of purchase for a credit.

Please refer to the following website in TGA for details:

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/ Tuesday, September 27, 2016
Issued at HKT 13:00